| Literature DB >> 27433431 |
Arjun S Sebastian1, Bradford L Currier1, Michelle J Clarke1, Dirk Larson1, Paul M Huddleston1, Ahmad Nassr1.
Abstract
STUDYEntities:
Keywords: cervical spine surgery; deep vein thrombosis; pulmonary embolus; venous thromboembolism
Year: 2015 PMID: 27433431 PMCID: PMC4947407 DOI: 10.1055/s-0035-1569056
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Fig. 1Frequency of comorbidities in the VTE and non-VTE groups. *Significant difference. Abbreviations: Afib, atrial fibrillation; CVI, chronic venous insufficiency; DM, diabetes mellitus; IHD, ischemic heart disease; PVD, peripheral vascular disease; VTE, venous thromboembolism.
Patient comorbidities predictive of VTE after cervical spine surgery
| Risk factor | Odds ratio | 95% CI |
|
|---|---|---|---|
| Chronic venous insufficiency | 3.40 | 1.35–8.58 | 0.01 |
| Atrial fibrillation | 2.69 | 1.53–4.79 | <0.001 |
| Obesity | 2.67 | 1.36–5.23 | 0.004 |
| Ischemic heart disease | 2.18 | 1.26–3.79 | 0.006 |
| Cancer | 1.45 | 0.89–2.37 | 0.137 |
| Hypertension | 1.28 | 0.82–1.93 | 0.298 |
| Peripheral vascular disease | 1.25 | 0.684–2.107 | 0.525 |
| Diabetes | 1.24 | 0.73–2.1 | 0.418 |
| Tobacco use | 0.45 | 0.204–0.965 | 0.04 |
Abbreviations: CI, confidence interval; VTE, venous thromboembolism.
Significant result.
Patient demographics for matched cohort analysis
| Variable | Case ( | Control ( |
|---|---|---|
| Age (y) | 58.6 ± 16.9 | 58.5 ± 16.9 |
| Male gender, | 56 (68.3%) | 112 (68.3%) |
| Length of stay (d) | 18.0 ± 16.6 | 4.6 ± 3.6 |
| Surgical indication, | ||
| Elective | 32 (39.0%) | 130 (79.3%) |
| Trauma | 28 (34.1%) | 17 (10.4%) |
| Oncology | 12 (14.6%) | 14 (8.5%) |
| Infection | 10 (12.2%) | 3 (1.8%) |
| Surgical approach, | ||
| Posterior | 50 (61.0%) | 123 (75.0%) |
| Anterior | 13 (15.9%) | 36 (22.0%) |
| Combined | 19 (23.2%) | 5 (3.0%) |
| Comorbid trauma | 11 (13.4%) | 2 (1.2%) |
| Estimated blood loss (mL) | 812.3 ± 948.9 | 339.2 ± 444.0 |
| Iliac crest autograft, | 32 (39.0%) | 23 (14.0%) |
| Number of levels, | ||
| 1 | 3 (3.7%) | 20 (12.2%) |
| 2–3 | 41 (50.0%) | 97 (59.1%) |
| 4+ | 38 (46.3%) | 47 (28.7%) |
| Paralysis, | 19 (23.2%) | 2 (1.2%) |
| Staged surgery, | 14 (17.1%) | 1 (0.6%) |
Univariate analysis: risk factor for VTE after cervical spine surgery
| Risk factor | Odds ratio | 95% CI |
|
|---|---|---|---|
| Staged surgery | 28.0 | 3.68–213 | 0.001 |
| Paralysis | 19.0 | 4.43–81.6 | <0.001 |
| Surgical indication | <0.001 | ||
| Infection versus elective | 18.5 | 3.39–101 | <0.001 |
| Trauma versus elective | 11.2 | 4.23–29.5 | 0.002 |
| Oncology versus elective | 5.2 | 1.79–15.1 | |
| Comorbid trauma | >10 | 9.0–∞ | <0.001 |
| Surgical approach | |||
| Combined versus posterior | 7.46 | 2.74–20.3 | <0.001 |
| Anterior versus posterior | 0.93 | 0.45–1.90 | 0.831 |
| Iliac crest autograft | 4.16 | 2.11–8.21 | <0.001 |
| Number of levels | |||
| 2–3 versus 1 | 2.7 | 0.75–9.49 | 0.129 |
| 4+ versus 1 | 4.84 | 1.35–17.4 | 0.016 |
| Estimated blood loss (300 mL or greater) | 1.66 | 1.65–1.66 | <0.001 |
| Length of stay (5 d or greater) | 3.47 | 3.15–3.81 | <0.001 |
Abbreviations: CI, confidence interval; VTE, venous thromboembolism.
Significant result.
Confidence interval generated using a profile likelihood approach.
Multivariate analysis: risk factors for VTE after cervical spine surgery
| Risk factor | Odds ratio | 95% CI |
|
|---|---|---|---|
| Staged surgery | 35.7 | 2.7–472 | 0.007 |
| Paralysis | 7.86 | 1.55–39.8 | 0.013 |
| Nonelective surgery | 6.29 | 2.51–15.8 | <0.001 |
Abbreviations: CI, confidence interval; VTE, venous thromboembolism.
Significant result.